However, whether DC vaccines could defeat the immune suppressive tumor microenvironment and efficiently activate and expand tumor-specific CD8+ and CD4+ T cells, which could further eliminate tumor cells, remained questionable [2]. Here, CD8A is linked to neoplasm.